Serum free light chain analysis

被引：33

作者：

Davids, Matthew S. ^{[1
,2
]}

Murali, Mandakolathur R. ^{[2
,3
]}

Kuter, David J. ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Ctr Hematol, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[3] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2010年 / 85卷 / 10期

关键词：

INDEPENDENT RISK-FACTOR; MONOCLONAL GAMMOPATHY; PROGRESSION; URINE; RATIO; IMMUNOFIXATION; AMYLOIDOSIS; REDUCTION; SURVIVAL; MARKERS;

D O I：

10.1002/ajh.21815

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In a variety of hematologic malignancies, immunoglobulin light chains (LC) are overproduced clonally and circulate without being linked by disulphide bonds to the immunoglobulin heavy chain. The recent development of a robust assay known as kappa and gamma "free'' LC (FLC) to quantify the levels of these unbound LC in the serum, and thereby determine their ratio, has led to an explosion of studies that demonstrate its utility in a wide range of hematologic disorders. This article summarizes laboratory testing for serum FLC, with a particular focus on clinical applications for the test. Am. J. Hematol. 85:787-790, 2010. (C) 2010 Wiley-Liss, Inc.

引用

页码：787 / 790

页数：4

共 50 条

[1] Serum free light chain analysis in multiple myeloma and plasma cell dyscrasias
Ozsan, Guner Hayri
Dispenzieri, Angela
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (01) : 65 - 73
[2] Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
Holding, Stephen
Spradbery, Dorothy
Hoole, Robin
Wilmot, Rachel
Shields, Michael L.
Levoguer, Alison M.
Dore, Philip C.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (01) : 83 - 88
[3] Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions
Milani, Paolo
Palladini, Giovanni
Merlini, Giampaolo
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S113 - S118
[4] Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
Moustafa, M. Alhaj
Rajkumar, S. V.
Dispenzieri, A.
Gertz, M. A.
Lacy, M. Q.
Buadi, F. K.
Hwa, Y. L.
Dingli, D.
Kapoor, P.
Hayman, S. R.
Lust, J. A.
Kyle, R. A.
Kumar, S. K.
LEUKEMIA, 2015, 29 (10) : 2033 - 2038
[5] Measurement uncertainty for serum free light chain assays: Estimation and implication on result interpretation
Wang, Li
Chan, Pak Cheung R.
CLINICAL BIOCHEMISTRY, 2013, 46 (4-5) : 381 - 384
[6] Extended Use of Serum Free Light Chain as a Biomarker in Lymphoproliferative Disorders A Comprehensive Review
Charafeddine, Khalil M.
Jabbour, Mark N.
Kadi, Raneem H.
Daher, Rose T.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 890 - 897
[7] Serum free light chain assays for the detection of monoclonal protein. Study from a population of 135 hospitalized patients
Musset, L.
Le Garff-Tavernier, M.
IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2009, 24 (03): : 149 - 154
[8] Serum free light chain and heavy/light chain analysis in patients with monoclonal gammopathy
Rothmann, Frank
Maschmeyer, Georg
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2011, 35 (05): : 271 - 278
[9] Serum Free Light Chain Analysis for Diagnosis, Monitoring, and Prognosis of Monodonal Gammopathies
Siegel, David
Bilotti, Elizabeth
van Hoeven, Karen H.
LABMEDICINE, 2009, 40 (06): : 363 - 366
[10] Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma
Dejoie, Thomas
Attal, Michel
Moreau, Philippe
Harousseau, Jean-Luc
Avet-Loiseau, Herve
HAEMATOLOGICA, 2016, 101 (03) : 356 - 362

← 1 2 3 4 5 →